BioTek's Cytation3 Cell Imaging Multi-Mode Reader recognized by SelectScience

NewsGuard 100/100 Score

For the second year in a row, BioTek Instruments was announced as winner of the SelectScience "Scientists' Choice Award for Best Drug Discovery Product". The award was given for BioTek's new Cytation™3 Cell Imaging Multi-Mode Reader, and was announced at ELRIG Drug Discovery in Manchester, UK.

The award recognizes products such as BioTek's Cytation3 and last year's winning Synergy™ Neo, as significantly contributing towards laboratory efforts around the world, and is nominated and voted for by drug discovery scientists.

SelectScience presented the award to BioTek's European Managing Director, Dirk Frese, who noted, "We are very grateful that scientists voted for the Cytation3… that's the best response you can get when developing a new product."

The unique patent pending design of Cytation3 combines automated digital microscopy and conventional multi-mode microplate detection in one modular and compact instrument. Fluorescence and brightfield imaging capture phenotypic and other cellular data, while patented Hybrid Technology™ combines filter- and monochromator-based optics for true multi-mode detection and meaningful quantitative data. This unique, parallel data acquisition platform allows scientists to collect more meaningful data, increase workflow efficiency, and reduce experimental time like never before. Additionally, a hit-picking function selects only cells meeting a pre-defined threshold for further analysis, thus saving processing time and valuable data storage space.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Experts identify highly drug-resistant infections from stem cell treatments In Mexico